Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 CAD | +2.48% | -11.16% | -23.33% |
Apr. 17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
Apr. 17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.33% | 106M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.73% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- NervGen Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022